An advisory panel of the Institute of Medicine released a report listing 100 health care concerns that the Obama administration should prioritize for its comparative-effectiveness reviews of drugs, medical devices and other treatments. The report is part of the government's effort to put more emphasis on scientific evidence in the practice of medicine.

Related Summaries